These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 20130415)
1. Appearance of HbeAg in an occult persistent hepatitis B virus infection. Paparella C; De Rosa F; Longo R; Cappiello G; Ursitti A; Rosa M; Morosetti M; Spanò A Intervirology; 2010; 53(3):173-5. PubMed ID: 20130415 [TBL] [Abstract][Full Text] [Related]
2. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727 [TBL] [Abstract][Full Text] [Related]
3. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland. Grabarczyk P; Garmiri P; Liszewski G; Doucet D; Sulkowska E; Brojer E; Allain JP; J Viral Hepat; 2010 Jun; 17(6):444-52. PubMed ID: 19780948 [TBL] [Abstract][Full Text] [Related]
6. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793 [TBL] [Abstract][Full Text] [Related]
7. Occult hepatitis B virus infection with positive hepatitis B e antigen. Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682 [TBL] [Abstract][Full Text] [Related]
9. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709 [TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of occult hepatitis B cases in Greek blood donors. Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945 [TBL] [Abstract][Full Text] [Related]
12. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?]. Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556 [TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP; Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [TBL] [Abstract][Full Text] [Related]
15. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191 [TBL] [Abstract][Full Text] [Related]
16. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection. Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744 [TBL] [Abstract][Full Text] [Related]
17. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations. Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845 [TBL] [Abstract][Full Text] [Related]
19. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B. Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290 [TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection: detection and significance. Gerlich WH; Bremer C; Saniewski M; Schüttler CG; Wend UC; Willems WR; Glebe D Dig Dis; 2010; 28(1):116-25. PubMed ID: 20460899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]